ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,631
Screening encounters
2,928
Diagnostic referrals
572
Outstanding pathways
226

Screening pathway

  1. Screening2,928Encounters
  2. Positive finding1,003Documented findings
  3. Referral572Diagnostic referrals
  4. Follow-up649Diagnostic visits
  5. Outcome346Resolved pathways

Stage totals use different units. Pending pathways: 226. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2026-04-16, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Screened participants

2631 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1762 · Expanded synthetic participant 1762Site C — Rural Outreach Programme
EXP-1768 · Expanded synthetic participant 1768Site A — Urban Referral Hub
EXP-1770 · Expanded synthetic participant 1770Site C — Rural Outreach Programme
EXP-1771 · Expanded synthetic participant 1771Site B — Peri-Urban Access Programme
EXP-1774 · Expanded synthetic participant 1774Site D — Community Engagement Programme
EXP-1778 · Expanded synthetic participant 1778Site B — Peri-Urban Access Programme
EXP-1780 · Expanded synthetic participant 1780Site C — Rural Outreach Programme
EXP-1781 · Expanded synthetic participant 1781Site B — Peri-Urban Access Programme
EXP-1785 · Expanded synthetic participant 1785Site D — Community Engagement Programme
EXP-1786 · Expanded synthetic participant 1786Site D — Community Engagement Programme
EXP-1789 · Expanded synthetic participant 1789Site E — Resource-Constrained Navigation Programme
EXP-1792 · Expanded synthetic participant 1792Site B — Peri-Urban Access Programme
EXP-1793 · Expanded synthetic participant 1793Site B — Peri-Urban Access Programme
EXP-1799 · Expanded synthetic participant 1799Site C — Rural Outreach Programme
EXP-1801 · Expanded synthetic participant 1801Site A — Urban Referral Hub
EXP-1802 · Expanded synthetic participant 1802Site E — Resource-Constrained Navigation Programme
EXP-1808 · Expanded synthetic participant 1808Site E — Resource-Constrained Navigation Programme
EXP-1809 · Expanded synthetic participant 1809Site B — Peri-Urban Access Programme
EXP-1810 · Expanded synthetic participant 1810Site E — Resource-Constrained Navigation Programme
EXP-1811 · Expanded synthetic participant 1811Site E — Resource-Constrained Navigation Programme
EXP-1812 · Expanded synthetic participant 1812Site A — Urban Referral Hub
EXP-1816 · Expanded synthetic participant 1816Site D — Community Engagement Programme
EXP-1817 · Expanded synthetic participant 1817Site D — Community Engagement Programme
EXP-1821 · Expanded synthetic participant 1821Site B — Peri-Urban Access Programme
EXP-1824 · Expanded synthetic participant 1824Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1203
HPV DNA
1289
Cytology
436

Navigation activity

Barrier documented
481
Contact attempt
836
Navigation intervention
207
Diagnostic booking
705
Diagnostic visit
649

Documented barriers

Contact difficulty
156
Transport difficulty
149
Appointment coordination
176

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.